Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Teva
Fish and Richardson
Express Scripts
Accenture

Generated: June 27, 2019

DrugPatentWatch Database Preview

DESMOPRESSIN ACETATE - Generic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

What are the generic sources for desmopressin acetate and what is the scope of desmopressin acetate freedom to operate?

Desmopressin acetate is the generic ingredient in eleven branded drugs marketed by Ferring Pharms Inc, Bedford, Hospira, Luitpold, Sagent Pharms, Sun Pharm Inds Ltd, Teva Pharms Usa, Ferring, Sun Pharm Inds, Bausch And Lomb, Apotex Inc, Sun Pharm, Zydus Pharms, Alyvant, Abhai Llc, Actavis Labs Fl Inc, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Mylan, and Novast Labs, and is included in thirty NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Desmopressin acetate has one hundred and seventy-three patent family members in thirty-five countries.

There are twenty drug master file entries for desmopressin acetate. Twenty-six suppliers are listed for this compound.

Synonyms for DESMOPRESSIN ACETATE
(Deamino-Cys1,D-Arg8)-Vasopressin
1-(3-Mercaptopropanoic Acid)-8-d-arginine Vasopressin Monoacetate
1-(3-mercaptopropanoic acid)-8-D-arginine vasopression monoacetate trihydrate
1-(3-Mercaptopropanoic acid)-8-D-argininevasopressin monoacetate (salt), trihydrate
1-(3-Mercaptopropionic acid)-8-D-arginine vasopression monoacetate
1-(3-mercaptopropionic acid)-8-D-arginine vasopression monoacetate trihydrate
1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin
1-(3-Mercaptopropionic acid)-8-D-arginine-vasopressin diacetate
1-(3-Mercaptopropionic acid)-8-D-arginine-vasopressin monoacetate (salt) trihydrate
1-(7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-(1-((2-amino-2-o
1-{[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-D-arginylglycinamide
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide acetate(1:1)
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide acetate(1:2)
1-Deamino-8-D-arginine vasopressin
1-deamino-8-D-arginine vasopressin acetate trihydrate
1-Deamino-8-D-arginine-vasopressin diacetate
1-Desamino-8-D-arginine vasopressin
1-desamino-8-D-arginine vasopressin acetate trihydrate
16679-58-6
16679-58-6 (Parent)
16789-98-3
1K12647SFC
242K8LE2BC
3576AH
3577AH
357D862
62288-83-9
62288-83-9 (monoacetate)
62357-86-2
62357-86-2 (monoacetate trihydrate)
679D586
789D983
8-d-Arginine-1-(3-mercapto-propanoic Acid)vasopresin Monoacetate
A810919
A833738
ABP000576
AC1L21V2
AC1L21V5
AC1L506T
AC1NSJXN
AC1Q5SZE
AC1Q5T0K
Adiuretin SD
AKOS015994650
AKOS025311518
AKOS030485983
AKOS030573306
AN-7545
BCP13206
BCP15458
BDBM50205308
C46H64N14O12S2
C46H64N14O12S2.C2H4O2
C46H64N14O12S2.C2H4O2.3H2O
CAS-62288-83-9
CD-644
CHEBI:4450
CHEBI:59728
CHEMBL1200556
CHEMBL1429
CHEMBL2138698
CHEMBL2358584
CONCENTRAID
CS-0952
CTK8F9082
D02235
DDAVP
DDAVP (NEEDS NO REFRIGERATION)
DDAVP (TN)
DDAVP ACETATE
DDAVP Nasal Spray
DDAVP Rhinal Tube
Deamino Arginine Vasopressin
Deamino-8-D-arginine, l-, vasopressin
Demopressin acetate
Desamino-8-D-arginine vasopressin, l-
Desmopresina
Desmopresina [INN-Spanish]
DESMOPRESSIN
Desmopressin (Acetate)
Desmopressin [INN:BAN]
Desmopressin acetate (needs NO refrigeration)
Desmopressin acetate (USAN)
Desmopressin acetate [USAN:JAN]
Desmopressin acetate [USAN:USP:JAN]
Desmopressin acetate anhydrous
Desmopressin acetate hydrate
Desmopressin acetate hydrate (JAN)
DESMOPRESSIN ACETATE PRESERVATIVE FREE
Desmopressin acetate trihydrate
Desmopressin Acetate(1:2)
Desmopressin Acetate(STIMATE, DDAVP)/
Desmopressin diacetate
Desmopressin diacetate anhydrous
Desmopressine
Desmopressine [INN-French]
Desmopressinum
Desmopressinum [INN-Latin]
Desmospray
DSSTox_CID_26864
DSSTox_GSID_46864
DSSTox_RID_81971
DTXSID4046864
EINECS 240-726-7
ENR1LLB0FP
FT-0603106
FT-0624526
FT-0653786
FT-0688024
H661
HS-2010
HY-17370
KS-00002WUQ
KW-8008
LS-161413
Minirin
Minirine
Minirinmelt (TN)
MLSVJHOYXJGGTR-IFHOVBQLSA-N
MolPort-006-069-425
NCGC00181133-01
NCGC00181133-02
NCGC00263573-01
NFLWUMRGJYTJIN-PNIOQBSNSA-N
Octim
Octostim
Presinex
SC-18848
SCHEMBL1172203
SCHEMBL14027607
SCHEMBL204511
Stimate
Stimate (TN)
Stimate injection
Stimate Nasal Spray
Tox21_112740
Tox21_112740_1
UNII-1K12647SFC
UNII-242K8LE2BC
UNII-ENR1LLB0FP
UNII-XB13HYU18U
VA10693
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, diacetate (salt)
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, monoacetate (salt)
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, monoacetate (salt), trihydrate
W-5074
XB13HYU18U
xoethyl)amino)-5-((diaminomethylene)amino)-1-oxopentan-2-yl)pyrrolidine-2-carboxamide diacetate

US Patents and Regulatory Information for DESMOPRESSIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-002 Apr 25, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abhai Llc DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 210371-001 Jan 28, 2019 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 021795-001 May 8, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-002 Jun 21, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alyvant NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for DESMOPRESSIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-002 Sep 6, 1995 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-002 Apr 25, 1995 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for DESMOPRESSIN ACETATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2712622 122017000006 Germany ➤ Sign Up PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
3225249 CA 2019 00023 Denmark ➤ Sign Up PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504
2712622 PA2017001 Lithuania ➤ Sign Up PRODUCT NAME: DESMOPRESINAS ARBA JO ACETATO DRUSKA; REGISTRATION NO/DATE: BE497271, 2016-05-04; LT1-16/3940/001-LT/1 6/3940/008
3225249 300983 Netherlands ➤ Sign Up PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513
2712622 LUC00015 Luxembourg ➤ Sign Up PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Chubb
Citi
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.